179 related articles for article (PubMed ID: 22410247)
1. Aglycone-focused randomization of 2-difluoromethylphenyl-type sialoside suicide substrates for neuraminidases.
Kai H; Hinou H; Nishimura S
Bioorg Med Chem; 2012 Apr; 20(8):2739-46. PubMed ID: 22410247
[TBL] [Abstract][Full Text] [Related]
2. A strategy for neuraminidase inhibitors using mechanism-based labeling information.
Hinou H; Miyoshi R; Takasu Y; Kai H; Kurogochi M; Arioka S; Gao XD; Miura N; Fujitani N; Omoto S; Yoshinaga T; Fujiwara T; Noshi T; Togame H; Takemoto H; Nishimura S
Chem Asian J; 2011 Apr; 6(4):1048-56. PubMed ID: 21305698
[TBL] [Abstract][Full Text] [Related]
3. Macrocyclic mechanism-based inhibitor for neuraminidases.
Kai H; Hinou H; Naruchi K; Matsushita T; Nishimura S
Chemistry; 2013 Jan; 19(4):1364-72. PubMed ID: 23233350
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Vibrio cholerae neuraminidase by a novel mechanism-based fluorescent labeling reagent.
Hinou H; Kurogochi M; Shimizu H; Nishimura S
Biochemistry; 2005 Sep; 44(35):11669-75. PubMed ID: 16128567
[TBL] [Abstract][Full Text] [Related]
5. Multivalent S-sialoside protein conjugates block influenza hemagglutinin and neuraminidase.
Yang Y; Liu HP; Yu Q; Yang MB; Wang DM; Jia TW; He HJ; He Y; Xiao HX; Iyer SS; Fan ZC; Meng X; Yu P
Carbohydr Res; 2016 Nov; 435():68-75. PubMed ID: 27710815
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2.
Khedri Z; Li Y; Cao H; Qu J; Yu H; Muthana MM; Chen X
Org Biomol Chem; 2012 Aug; 10(30):6112-20. PubMed ID: 22641268
[TBL] [Abstract][Full Text] [Related]
7. A new class of mechanism-based inhibitors for Trypanosoma cruzi trans-sialidase and their influence on parasite virulence.
Carvalho ST; Sola-Penna M; Oliveira IA; Pita S; Gonçalves AS; Neves BC; Sousa FR; Freire-de-Lima L; Kurogochi M; Hinou H; Nishimura S; Mendonça-Previato L; Previato JO; Todeschini AR
Glycobiology; 2010 Aug; 20(8):1034-45. PubMed ID: 20466651
[TBL] [Abstract][Full Text] [Related]
8. Understanding viral neuraminidase inhibition by substituted difluorosialic acids.
Weck S; Robinson K; Smith MR; Withers SG
Chem Commun (Camb); 2015 Feb; 51(14):2933-5. PubMed ID: 25587931
[TBL] [Abstract][Full Text] [Related]
9. The synthesis of a series of deoxygenated 2,3-difluoro-N-acteylneuraminic acid derivatives as potential sialidase inhibitors.
Hader S; Watts AG
Carbohydr Res; 2013 Jun; 374():23-8. PubMed ID: 23618621
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional-group tuning in the design of neuraminidase inhibitors.
Sabesan S; Neira S; Wasserman Z
Carbohydr Res; 1995 Feb; 267(2):239-61. PubMed ID: 7895225
[TBL] [Abstract][Full Text] [Related]
11. 2β-3,4-Unsaturated sialic acid derivatives: Synthesis optimization, and biological evaluation as Newcastle disease virus hemagglutinin-neuraminidase inhibitors.
La Rocca P; Rota P; Piccoli M; Cirillo F; Ghiroldi A; Franco V; Allevi P; Anastasia L
Bioorg Med Chem; 2020 Jul; 28(14):115563. PubMed ID: 32616179
[TBL] [Abstract][Full Text] [Related]
12. Chemoenzymatic synthesis of sialosides containing C7-modified sialic acids and their application in sialidase substrate specificity studies.
Khedri Z; Li Y; Muthana S; Muthana MM; Hsiao CW; Yu H; Chen X
Carbohydr Res; 2014 May; 389():100-11. PubMed ID: 24680514
[TBL] [Abstract][Full Text] [Related]
13. Chemoenzymatic Syntheses of Sialylated Oligosaccharides Containing C5-Modified Neuraminic Acids for Dual Inhibition of Hemagglutinins and Neuraminidases.
Birikaki L; Pradeau S; Armand S; Priem B; Márquez-Domínguez L; Reyes-Leyva J; Santos-López G; Samain E; Driguez H; Fort S
Chemistry; 2015 Jul; 21(30):10903-12. PubMed ID: 26088695
[TBL] [Abstract][Full Text] [Related]
14. Focused library with a core structure extracted from natural products and modified: application to phosphatase inhibitors and several biochemical findings.
Hirai G; Sodeoka M
Acc Chem Res; 2015 May; 48(5):1464-73. PubMed ID: 25894598
[TBL] [Abstract][Full Text] [Related]
15. Sialidase substrate specificity studies using chemoenzymatically synthesized sialosides containing C5-modified sialic acids.
Cao H; Li Y; Lau K; Muthana S; Yu H; Cheng J; Chokhawala HA; Sugiarto G; Zhang L; Chen X
Org Biomol Chem; 2009 Dec; 7(24):5137-45. PubMed ID: 20024109
[TBL] [Abstract][Full Text] [Related]
16. Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities.
Li J; Zheng M; Tang W; He PL; Zhu W; Li T; Zuo JP; Liu H; Jiang H
Bioorg Med Chem Lett; 2006 Oct; 16(19):5009-13. PubMed ID: 16876409
[TBL] [Abstract][Full Text] [Related]
17. High-throughput substrate specificity studies of sialidases by using chemoenzymatically synthesized sialoside libraries.
Chokhawala HA; Yu H; Chen X
Chembiochem; 2007 Jan; 8(2):194-201. PubMed ID: 17195254
[TBL] [Abstract][Full Text] [Related]
18. Prenylated pterocarpans as bacterial neuraminidase inhibitors.
Nguyen PH; Nguyen TN; Kang KW; Ndinteh DT; Mbafor JT; Kim YR; Oh WK
Bioorg Med Chem; 2010 May; 18(9):3335-44. PubMed ID: 20363636
[TBL] [Abstract][Full Text] [Related]
19. Triazole-linked transition state analogs as selective inhibitors against V. cholerae sialidase.
Slack TJ; Li W; Shi D; McArthur JB; Zhao G; Li Y; Xiao A; Khedri Z; Yu H; Liu Y; Chen X
Bioorg Med Chem; 2018 Nov; 26(21):5751-5757. PubMed ID: 30389408
[TBL] [Abstract][Full Text] [Related]
20. Biocatalysis versus Molecular Recognition in Sialoside-Selective Neuraminidase Biosensing.
Alshanski I; Toraskar S; Shitrit A; Gordon-Levitan D; Jain P; Kikkeri R; Hurevich M; Yitzchaik S
ACS Chem Biol; 2023 Mar; 18(3):605-614. PubMed ID: 36792550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
